Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stop: the medical and human rights scandal in Bahrain.

International journal of clinical practice·2011

Same author

Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2011

Same author

Transferable SAFT-VR models for the calculation of the fluid phase equilibria in reactive mixtures of carbon dioxide, water, and n-alkylamines in the context of carbon capture.

The journal of physical chemistry. B·2011

Same author

Structural and functional failure of TVT by trimming of the extruded edge.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011

Same author

Cholesteric order in systems of helical Yukawa rods.

Journal of physics. Condensed matter : an Institute of Physics journal·2011

Same author

Communicating about death and dying.

International journal of clinical practice·2011

Same journal

Treatment of dyslipidaemias with fluvastatin.

British journal of clinical practice. Supplement·2009

Same journal

Lipoprotein(a) as a marker for coronary heart disease.

British journal of clinical practice. Supplement·2009

Same journal

Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.

British journal of clinical practice. Supplement·2009

Same journal

Fluvastatin in combination with other lipid-lowering agents.

British journal of clinical practice. Supplement·2009

Same journal

The patient at risk: who should we be treating?

British journal of clinical practice. Supplement·2009

Same journal

Safety profile of fluvastatin.

British journal of clinical practice. Supplement·2009

See all related articles

Search research articles

Related Experiment Videos

Risk factor management: the cardiologist's perspective.

¹Guy's Hospital, London, UK.

British Journal of Clinical Practice. Supplement

|June 6, 2009

Summary

This summary is machine-generated.

Managing cardiovascular disease requires a comprehensive approach to risk factors like smoking, hypertension, and hyperlipidemia. Effective prevention strategies, tailored to individual patients, are crucial for slowing disease progression and improving outcomes.

Related Experiment Videos

Area of Science:

Cardiology
Preventive Medicine
Public Health

Background:

Cardiovascular disease management often focuses on secondary prevention after disease onset.
Primary prevention is less contentious but crucial for long-term health.
Risk factors for cardiovascular disease are additive and require holistic assessment.

Purpose of the Study:

To emphasize the importance of comprehensive risk factor management in cardiology.
To highlight the role of prevention in slowing disease progression and inducing regression.
To address educational gaps in risk factor management for both patients and cardiologists.

Main Methods:

Review of current practices in cardiovascular disease prevention and management.
Analysis of the additive nature of cardiovascular risk factors.
Discussion of pharmacologic and non-pharmacologic interventions.

Main Results:

Attention to preventive details, including smoking cessation, hypertension control, and hyperlipidemia management, is key.
Therapeutic interventions must be individualized, considering potential metabolic side effects of medications.
A team-based approach, with the patient as a central member, is essential for effective management.

Conclusions:

Preventive cardiology, focusing on detailed risk factor management, offers superior long-term benefits over interventional procedures alone.
Improved education for patients and cardiologists on risk factors is vital for enhancing preventive strategies.
Addressing the interplay of multiple risk factors is paramount for successful cardiovascular disease management.